Cyclerion Therapeutics (CYCN) Non-Current Assets (2019 - 2025)
Historic Non-Current Assets for Cyclerion Therapeutics (CYCN) over the last 7 years, with Q3 2025 value amounting to $5.4 million.
- Cyclerion Therapeutics' Non-Current Assets changed 0.0% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.4 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $5.4 million for FY2024, which is 0.0% changed from last year.
- According to the latest figures from Q3 2025, Cyclerion Therapeutics' Non-Current Assets is $5.4 million, which was down 0.0% from $5.4 million recorded in Q2 2025.
- Cyclerion Therapeutics' 5-year Non-Current Assets high stood at $55.5 million for Q1 2021, and its period low was $2.7 million during Q2 2021.
- Its 5-year average for Non-Current Assets is $7.1 million, with a median of $5.4 million in 2023.
- As far as peak fluctuations go, Cyclerion Therapeutics' Non-Current Assets tumbled by 9599.42% in 2021, and later soared by 7928.95% in 2024.
- Over the past 5 years, Cyclerion Therapeutics' Non-Current Assets (Quarter) stood at $3.9 million in 2021, then dropped by 15.88% to $3.3 million in 2022, then soared by 64.16% to $5.4 million in 2023, then changed by 0.0% to $5.4 million in 2024, then changed by 0.0% to $5.4 million in 2025.
- Its Non-Current Assets stands at $5.4 million for Q3 2025, versus $5.4 million for Q2 2025 and $5.4 million for Q1 2025.